NASDAQ:SGHT Sight Sciences (SGHT) Stock Price, News & Analysis $8.76 +0.51 (+6.13%) As of 03:20 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Sight Sciences Stock (NASDAQ:SGHT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sight Sciences alerts:Sign Up Key Stats Today's Range$8.53▼$9.0150-Day Range$7.09▼$9.3652-Week Range$3.37▼$9.71Volume169,194 shsAverage Volume272,943 shsMarket Capitalization$482.37 millionP/E RatioN/ADividend YieldN/APrice Target$9.00Consensus RatingModerate Buy Company Overview Sight Sciences, Inc. is a medical technology company focused on developing and commercializing treatments for ophthalmic diseases. The company designs devices intended to address underlying causes of conditions such as glaucoma and dry eye disease, with an emphasis on less invasive procedures that can be performed in clinical settings. Its product portfolio includes the OMNI Surgical System, a device used in minimally invasive glaucoma surgery to perform canaloplasty and trabeculotomy procedures. Sight Sciences also offers the TearCare System, which is designed to apply controlled thermal therapy to the eyelids to help treat meibomian gland dysfunction, a common contributor to evaporative dry eye disease. Founded in 2010 and headquartered in Menlo Park, California, Sight Sciences markets its products primarily through ophthalmology and optometry practices. The company serves eye-care providers and patients in the United States and has pursued international commercialization of its technologies. Sight Sciences trades on the Nasdaq under the symbol SGHT.AI Generated. May Contain Errors. Read More Sight Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreSGHT MarketRank™: 1.576299973865 of 5 starsSight Sciences scored higher than 32% of companies evaluated by MarketBeat, and ranked 738th out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingModerate Buy Consensus RatingSight Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on no strong buy ratings, 6 buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Sight Sciences is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageSight Sciences has only been the subject of 4 research reports in the past 90 days.Read more about Sight Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Sight Sciences are expected to grow in the coming year, from ($0.52) to ($0.42) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sight Sciences is -15.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sight Sciences is -15.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSight Sciences has a P/B Ratio of 7.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Sight Sciences' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.69% of the float of Sight Sciences has been sold short.Short Interest Ratio / Days to CoverSight Sciences has a short interest ratio ("days to cover") of 4.13.Change versus previous monthShort interest in Sight Sciences has recently increased by 13.05%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSight Sciences does not currently pay a dividend.Dividend GrowthSight Sciences does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment0.82 News SentimentSight Sciences has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Sight Sciences this week, compared to 3 articles on an average week. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Sight Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $429,157.00 in company stock.Percentage Held by Insiders30.40% of the stock of Sight Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.51% of the stock of Sight Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Sight Sciences' insider trading history. Receive SGHT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sight Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGHT Stock News HeadlinesHC Wainwright Initiates Coverage on Sight Sciences With Buy Rating, $14 Price TargetOctober 15 at 8:40 AM | marketscreener.comMHead to Head Comparison: Nano-X Imaging (NASDAQ:NNOX) and Sight Sciences (NASDAQ:SGHT)October 12 at 3:58 AM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 15 at 1:00 AM | Base Camp Trading (Ad)Sight Sciences, Inc. (NASDAQ:SGHT) Stock Has Average Price Target of $8.38 According to AnalystsOctober 12 at 2:15 AM | americanbankingnews.comSight Sciences: Signs Of Progress, But Plenty Of Work RemainsOctober 9, 2026 | seekingalpha.comSight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target IncreasesOctober 8, 2026 | uk.finance.yahoo.comSight Sciences (NASDAQ:SGHT) Stock: Insider James Rodberg Sells 7,208 SharesOctober 7, 2026 | americanbankingnews.comSight Sciences (NASDAQ:SGHT) Stock: Insider Brenton Taylor Sells 2,988 SharesOctober 6, 2026 | insidertrades.comSee More Headlines SGHT Stock Analysis - Frequently Asked Questions How have SGHT shares performed this year? Sight Sciences' stock was trading at $7.93 at the beginning of 2026. Since then, SGHT stock has increased by 11.8% and is now trading at $8.8650. How were Sight Sciences' earnings last quarter? Sight Sciences, Inc. (NASDAQ:SGHT) released its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.10. The company earned $23.39 million during the quarter, compared to analysts' expectations of $21.72 million. Sight Sciences had a negative trailing twelve-month return on equity of 43.39% and a negative net margin of 35.69%. Read the conference call transcript. When did Sight Sciences IPO? Sight Sciences (SGHT) raised $235 million in an initial public offering on Wednesday, July 14th 2021. The company issued 10,000,000 shares at $23.00-$24.00 per share. How do I buy shares of Sight Sciences? Shares of SGHT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sight Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sight Sciences investors own include Boeing (BA), Omega Therapeutics (OMGAQ), Aclaris Therapeutics (ACRS), Aldeyra Therapeutics (ALDX), Aligos Therapeutics (ALGS), Allogene Therapeutics (ALLO) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/05/2026Today10/15/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SGHT CIK1531177 Webwww.sightsciences.com Phone877-266-1144FaxN/AEmployees186Year Founded2011Price Target and Rating Average Price Target for Sight Sciences$9.00 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+1.6%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$38.43 million Net Margins-35.69% Pretax Margin-35.73% Return on Equity-43.39% Return on Assets-22.86% Debt Debt-to-Equity Ratio0.58 Current Ratio4.95 Quick Ratio4.67 Sales & Book Value Annual Sales$77.36 million Price / Sales6.31 Cash FlowN/A Price / Cash FlowN/A Book Value$1.21 per share Price / Book7.32Miscellaneous Outstanding Shares55,090,000Free Float38,341,000Market Cap$488.10 million OptionableOptionable Beta2.45 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:SGHT) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
